Trusted Resources: News & Events
Latest announcements and gatherings
Vaso-Occlusive Crisis: The Future of Treating Patients With Sickle Cell Disease in Emergency Departments
+myBinder
Corinna Schultz, MD, Shares How Pediatricians Can Discuss Sickle Cell Trait With Patients, Families
+myBinder
From Early Hypothesis to Clinical Data About Reducing Vaso-Occlusive Episodes with Arginine Therapy
+myBinder
Corinna Schultz, MD: Does Sickle Cell Trait Get Discussed?
+myBinder
Claudia Morris, MD, Uncovers Potential New Mechanism of Action for Hydroxyurea
+myBinder
Arginine Therapy Shows Positive Impacts on Sickle Cell Disease in ASH 2022 Data
+myBinder
The Warrior Network – Sickle Cell Community Consortium
+myBinder
Sickle Cell Disease and Sickle Cell Trait – SCDAA Brochure
+myBinder
SCDAA Releases Comments on the CDC’s Opioid Guidelines
+myBinder
The Sickle Cell Disease Association of America (SCDAA) Recognized for Leadership
+myBinder
$100,000 Grant Allows National Expansion in Expert Care of Sickle Cell Patients
+myBinder
SCDAA Partners With Phi Beta Sigma Fraternity
+myBinder
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic Partnership
+myBinder
Sickle Cell Disease: After Years of Neglect Some Promise for Sufferers
+myBinder
Novartis wins Medicaid approval for new sickle cell drug in key US states
+myBinder
Novel Sickle Cell Drug Causes Radical Results in End of Life Patients
+myBinder
Edward Ivy, MD, MPH: A Comprehensive Perspective on Sickle Cell Disease
+myBinder
Sickle Cell Management During the Blood Crisis With Edward Ivy, MD, MPH
+myBinder
Regina Hartfield Is Now the CEO and President of SCDAA
+myBinder
Q&A With Regina Hartfield, New CEO of the SCDAA
+myBinder
Sickle Cell Disease Association of America, Inc. Names New CEO & President
+myBinder
Sickle Cell Disease Camp – JWCF at RoundUp River Ranch
+myBinder
Don’t forget to join the oneSCDvoice community!
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.